SpringWorks Therapeutics, Inc. (SWTX)
USD 38.81
(-9.9%)
USD 38.81
(-9.9%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -168.99 Million USD | -171.53% |
| 2022 | -62.23 Million USD | 39.38% |
| 2021 | -102.67 Million USD | 28.88% |
| 2020 | -144.35 Million USD | 55.94% |
| 2019 | -327.65 Million USD | -617.78% |
| 2018 | -45.64 Million USD | -344.44% |
| 2017 | -10.27 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -111.46 Million USD | 34.04% |
| 2024 Q2 | -72.83 Million USD | 34.66% |
| 2023 Q1 | -95.35 Million USD | -53.2% |
| 2023 Q4 | -168.99 Million USD | -84.57% |
| 2023 Q2 | -107.39 Million USD | -12.63% |
| 2023 FY | -168.99 Million USD | -171.53% |
| 2023 Q3 | -91.56 Million USD | 14.74% |
| 2022 Q2 | -63.78 Million USD | 16.14% |
| 2022 Q3 | -470.69 Million USD | -637.9% |
| 2022 FY | -62.23 Million USD | 39.38% |
| 2022 Q1 | -76.06 Million USD | 25.91% |
| 2022 Q4 | -62.23 Million USD | 86.78% |
| 2021 Q1 | -93.15 Million USD | 35.47% |
| 2021 FY | -102.67 Million USD | 28.88% |
| 2021 Q4 | -102.67 Million USD | -11.32% |
| 2021 Q3 | -92.22 Million USD | -11.63% |
| 2021 Q2 | -82.61 Million USD | 11.31% |
| 2020 Q2 | -226.66 Million USD | 27.13% |
| 2020 Q4 | -144.35 Million USD | -70.17% |
| 2020 Q3 | -84.83 Million USD | 62.57% |
| 2020 FY | -144.35 Million USD | 55.94% |
| 2020 Q1 | -311.07 Million USD | 5.06% |
| 2019 Q2 | -185.29 Million USD | -505.91% |
| 2019 Q1 | 45.64 Million USD | 200.0% |
| 2019 FY | -327.65 Million USD | -617.78% |
| 2019 Q4 | -327.65 Million USD | 4.7% |
| 2019 Q3 | -343.82 Million USD | -85.56% |
| 2018 Q1 | 10.27 Million USD | 0.0% |
| 2018 Q4 | -45.64 Million USD | 0.0% |
| 2018 FY | -45.64 Million USD | -344.44% |
| 2017 FY | -10.27 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -202.102% |
| Alkermes plc | -166.73 Million USD | -1.354% |
| Agenus Inc. | 274.13 Million USD | 161.647% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 109.038% |
| Aptorum Group Limited | 1.35 Million USD | 12553.226% |
| Ardelyx, Inc. | 34.51 Million USD | 589.673% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 4048.505% |
| Bicycle Therapeutics plc | -481.46 Million USD | 64.9% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 567.317% |
| ChromaDex Corporation | -24.04 Million USD | -602.745% |
| Chimerix, Inc. | -25.51 Million USD | -562.288% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 2525.289% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -613.756% |
| CRISPR Therapeutics AG | -150.84 Million USD | -12.033% |
| Precision BioSciences, Inc. | -85.41 Million USD | -97.864% |
| Dyadic International, Inc. | -6.37 Million USD | -2549.63% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -960.667% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2304.775% |
| Lantern Pharma Inc. | -21.7 Million USD | -678.666% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -52.886% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1878.14% |
| Incyte Corporation | -3.17 Billion USD | 94.677% |
| IO Biotech, Inc. | -140.69 Million USD | -20.112% |
| Jaguar Health, Inc. | 29.39 Million USD | 674.992% |
| Novavax, Inc. | -298.29 Million USD | 43.346% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 3266.498% |
| Opthea Limited | 28.15 Million USD | 700.182% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -906.588% |
| ContextLogic Inc. | -232 Million USD | 27.157% |
| MiMedx Group, Inc. | -33.9 Million USD | -398.499% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1757.636% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -7193.657% |
| NextCure, Inc. | -6.47 Million USD | -2509.171% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -234.639% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -2549.255% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1489.396% |
| Vaxcyte, Inc. | -368.22 Million USD | 54.105% |
| PDS Biotechnology Corporation | -32.7 Million USD | -416.667% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1078.099% |
| Pharming Group N.V. | 109.8 Million USD | 253.907% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -871.465% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 3.558% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -812.512% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -812.512% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -2280.225% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -2783.891% |
| Acelyrin, Inc. | -216.9 Million USD | 22.087% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -2912.263% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -9702.552% |
| Summit Therapeutics Inc. | 34.67 Million USD | 587.385% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -2384.139% |
| Senti Biosciences, Inc. | 1.74 Million USD | 9812.414% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 8.456% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -118.197% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -2687.793% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 169487.285% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 27010.191% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -44.384% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -0.454% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 252.427% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -2124.803% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -30.889% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 2551.136% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 30.272% |
| Immix Biopharma, Inc. | -17.5 Million USD | -865.151% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 46.639% |
| MEI Pharma, Inc. | -3.7 Million USD | -4461.296% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1450.779% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 204.485% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 708.052% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2304.775% |
| Precigen, Inc. | -481 Thousand USD | -35034.304% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1300.17% |
| AlloVir, Inc. | -62.69 Million USD | -169.565% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -203.873% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 374.051% |
| ImmuCell Corporation | 10.99 Million USD | 1637.647% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -9.634% |
| Onconetix, Inc. | 5.33 Million USD | 3269.802% |
| PureTech Health plc | -167.19 Million USD | -1.076% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -454.813% |
| Elevation Oncology, Inc. | -19.11 Million USD | -783.963% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -3342.575% |
| Seer, Inc. | -4.24 Million USD | -3885.755% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -603.066% |
| Innoviva, Inc. | 255.56 Million USD | 166.127% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -202.513% |
| ESSA Pharma Inc. | -33.62 Million USD | -402.641% |
| GlycoMimetics, Inc. | -40.98 Million USD | -312.342% |
| GT Biopharma, Inc. | -1.02 Million USD | -16452.008% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -149.319% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 375.88% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -26.042% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1119.659% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -485.328% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -224228.988% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -447.586% |
| Aptose Biosciences Inc. | -8.19 Million USD | -1962.22% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -5300.928% |
| Soligenix, Inc. | -4.95 Million USD | -3312.959% |
| Century Therapeutics, Inc. | 847 Thousand USD | 20052.302% |
| Kura Oncology, Inc. | -20.11 Million USD | -740.024% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -312.931% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1912.336% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 9376.855% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -5186.081% |
| Autolus Therapeutics plc | -186.59 Million USD | 9.434% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -242.763% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 38.724% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 593.16% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 202.816% |
| GRI Bio, Inc. | -1.79 Million USD | -9320.067% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1781.277% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -408.152% |
| IGM Biosciences, Inc. | -72.6 Million USD | -132.758% |
| INmune Bio, Inc. | -25.41 Million USD | -565.051% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 211.954% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -233.595% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -940.016% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -5757.897% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 544.551% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -310.334% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 630.017% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 144.714% |
| Verastem, Inc. | -37.27 Million USD | -353.34% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1762.625% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -225.857% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1016.591% |
| Histogen Inc. | -7.48 Million USD | -2157.192% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -682.142% |
| Surrozen, Inc. | -32.66 Million USD | -417.377% |
| Organovo Holdings, Inc. | -1.5 Million USD | -11114.068% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3920.375% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 991.319% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 6560.092% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 4166.314% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1916.382% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -289.015% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1059.344% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 46.653% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -23304.703% |
| Apollomics, Inc. | -27.39 Million USD | -516.886% |
| Amarin Corporation plc | -191.04 Million USD | 11.539% |
| Mesoblast Limited | 55.96 Million USD | 401.978% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1058.777% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -568.18% |
| Synaptogenix, Inc. | -28.66 Million USD | -489.627% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -17955.128% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 446.787% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -19503.08% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -2225.821% |
| Exelixis, Inc. | -73.05 Million USD | -131.343% |
| Better Therapeutics, Inc. | -860 Thousand USD | -19550.698% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -603.769% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 29.985% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 23059.354% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -2172.021% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 13576.555% |
| Gritstone bio, Inc. | 39.49 Million USD | 527.946% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -100.944% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -6320.479% |
| Avid Bioservices, Inc. | 169.72 Million USD | 199.569% |
| Insmed Incorporated | 721.62 Million USD | 123.419% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1748.666% |
| MediWound Ltd. | -5.32 Million USD | -3075.423% |
| OmniAb, Inc. | 9.2 Million USD | 1936.314% |
| Alector, Inc. | -35.63 Million USD | -374.215% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 296.573% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -3329.302% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1376.501% |
| Zai Lab Limited | -775 Million USD | 78.194% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 149.624% |
| Aura Biosciences, Inc. | -21.52 Million USD | -685.115% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -104.893% |
| Immunic, Inc. | -45.34 Million USD | -272.73% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 12.535% |
| Veracyte, Inc. | -203.82 Million USD | 17.087% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 126.476% |
| FibroGen, Inc. | 56.76 Million USD | 397.701% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1997.765% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -5877.754% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -8062.686% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 103.682% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -4958.246% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -1.827% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1046.12% |
| Galecto, Inc. | -21.21 Million USD | -696.55% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -610.515% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 110.768% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -590.569% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1368.636% |
| XBiotech Inc. | -200.02 Million USD | 15.512% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -100.944% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 3832.244% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -379.245% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -118.856% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 3069.531% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 0.833% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -82.948% |
| Vaxxinity, Inc. | 10.13 Million USD | 1767.943% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 122.953% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1469.493% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -156.225% |
| NexImmune, Inc. | -3.13 Million USD | -5292.956% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -4794.642% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1018.331% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -523.601% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1782.743% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -135558.037% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -316.534% |
| Ainos, Inc. | 4.07 Million USD | 4244.163% |
| Pluri Inc. | 22.82 Million USD | 840.269% |
| Prothena Corporation plc | -608.34 Million USD | 72.22% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -42.305% |
| Celularity Inc. | 65.19 Million USD | 359.236% |
| Rallybio Corporation | -24.1 Million USD | -601.17% |
| Cue Biopharma, Inc. | -33.81 Million USD | -399.707% |
| MeiraGTx Holdings plc | -40.3 Million USD | -319.324% |
| Omeros Corporation | 331.17 Million USD | 151.029% |
| Humacyte, Inc. | -22.48 Million USD | -651.561% |
| Immunocore Holdings plc | -358.59 Million USD | 52.873% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -587.674% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -446.895% |
| Blueprint Medicines Corporation | 702.83 Million USD | 124.045% |
| CalciMedica, Inc. | -5.53 Million USD | -2955.986% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 10.214% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1554.553% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -322.1% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -408.213% |
| Pulmatrix, Inc. | -10.41 Million USD | -1522.31% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -2727.439% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -343.071% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -51.699% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -181.923% |
| Cytokinetics, Incorporated | 642.37 Million USD | 126.308% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -2802.215% |
| Nutriband Inc. | -251.65 Thousand USD | -67053.308% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -395.313% |
| Vor Biopharma Inc. | 4.3 Million USD | 4030.14% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 97.2% |
| Evogene Ltd. | -19.63 Million USD | -760.731% |
| ProKidney Corp. | -56.23 Million USD | -200.512% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -247.214% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1729.518% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 112.391% |
| CorMedix Inc. | -43.05 Million USD | -292.535% |
| BioLineRx Ltd. | 7.33 Million USD | 2403.653% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -515.314% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 466.212% |
| Atai Life Sciences N.V. | -28.55 Million USD | -491.764% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 7676.499% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -640.691% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1052.895% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -125.106% |
| MediciNova, Inc. | -50.78 Million USD | -232.777% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -114.448% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -751160.28% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2519.042% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 15.426% |
| Biomea Fusion, Inc. | -166.57 Million USD | -1.456% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 5.576% |
| Mereo BioPharma Group plc | -51.46 Million USD | -228.345% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -78.183% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 42.471% |
| Absci Corporation | -72.59 Million USD | -132.783% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3801.183% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 27.914% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -79.38% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -76.597% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -332.514% |
| Allakos Inc. | -24.97 Million USD | -576.661% |
| Imunon, Inc. | -4.21 Million USD | -3910.487% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1046.357% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -24.812% |
| BioAtla, Inc. | -109.01 Million USD | -55.027% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 23059.354% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -17897.444% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1512.302% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -697.038% |
| XOMA Corporation | -29 Million USD | -482.745% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -920.507% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1774.401% |
| aTyr Pharma, Inc. | -7.44 Million USD | -2168.707% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -35.592% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 18.816% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -106.65% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -82.18% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -19569.361% |
| Akari Therapeutics, Plc | -3.84 Million USD | -4295.215% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 10513.275% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 112.238% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -14123.636% |
| UroGen Pharma Ltd. | 4.39 Million USD | 3948.691% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 248.92% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 234940.61% |
| Orgenesis Inc. | 21.78 Million USD | 875.78% |
| Entera Bio Ltd. | -10.62 Million USD | -1489.952% |
| GH Research PLC | -78.07 Million USD | -116.448% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -658.238% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -533.917% |
| Xencor, Inc. | 29.64 Million USD | 670.085% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -8479.296% |
| Replimune Group, Inc. | 1.41 Million USD | 12068.555% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -68903.871% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -33.681% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -14123.636% |
| Portage Biotech Inc. | -4.98 Million USD | -3292.813% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -751160.28% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -155.582% |
| OncoCyte Corporation | -6.56 Million USD | -2474.981% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 18931.463% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -3609.597% |
| Purple Biotech Ltd. | -14.13 Million USD | -1095.332% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -611.382% |
| scPharmaceuticals Inc. | -6.54 Million USD | -2482.063% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -912.427% |
| HilleVax, Inc. | -165.48 Million USD | -2.122% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -6558.629% |
| Tharimmune, Inc. | -10.93 Million USD | -1445.41% |
| Genprex, Inc. | -6.73 Million USD | -2408.241% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 54.178% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -91.042% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -11962.527% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -4994.928% |
| OKYO Pharma Limited | -826.84 Thousand USD | -20338.581% |
| Savara Inc. | 153 Thousand USD | 110554.902% |
| Curis, Inc. | -23.88 Million USD | -607.481% |
| Daré Bioscience, Inc. | -5.15 Million USD | -3176.443% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -21677.498% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -2622.229% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 14361.266% |
| BeiGene, Ltd. | -2.25 Billion USD | 92.499% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1469.664% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 72.214% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 8.939% |
| Erasca, Inc. | -37.21 Million USD | -354.095% |
| bluebird bio, Inc. | 108.57 Million USD | 255.655% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -13021.898% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 144.62% |
| DBV Technologies S.A. | -126.98 Million USD | -33.082% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -13021.898% |
| Moderna, Inc. | -2.9 Billion USD | 94.187% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1532.496% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1454.987% |
| Molecular Templates, Inc. | 707 Thousand USD | 24003.253% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -438.701% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 148.757% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -105.937% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -84.232% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -423.661% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -391.61% |
| MacroGenics, Inc. | -66.98 Million USD | -152.289% |
| RenovoRx, Inc. | -1.17 Million USD | -14307.161% |
| Adicet Bio, Inc. | -138.78 Million USD | -21.766% |
| Prime Medicine, Inc. | -27.94 Million USD | -504.832% |
| Aditxt, Inc. | 18.12 Million USD | 1032.603% |
| Adagene Inc. | -87.62 Million USD | -92.858% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3957.11% |
| Quantum-Si incorporated | -118.55 Million USD | -42.544% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 569.368% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -2161.062% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -248.381% |
| SciSparc Ltd. | -2.06 Million USD | -8083.826% |
| Vericel Corporation | 1.27 Million USD | 13333.829% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1309.275% |
| Minerva Neurosciences, Inc. | 41 Million USD | 512.143% |
| Generation Bio Co. | 31.44 Million USD | 637.382% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 3.631% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -446.506% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 244.945% |
| Invivyd, Inc. | -198.47 Million USD | 14.853% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -87.212% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -6948.289% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -138.729% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -2376.132% |
| 2seventy bio, Inc. | 181.71 Million USD | 193.001% |
| ADMA Biologics, Inc. | 90.06 Million USD | 287.636% |
| Clene Inc. | 3.34 Million USD | 5159.76% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1760.636% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -685.626% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2519.042% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 50.891% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -549.993% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 195.12% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -4030.349% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 3478.569% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -3144.308% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -29.694% |
| Evaxion Biotech A/S | 5.28 Million USD | 3296.538% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -50.128% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -28.736% |
| Trevena, Inc. | 2.25 Million USD | 7584.322% |
| Surrozen, Inc. | -32.66 Million USD | -417.377% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -228.084% |
| Cingulate Inc. | 3.08 Million USD | 5582.108% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -5654.035% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 2451.412% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1718.877% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -113.048% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -28.561% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -60.122% |
| Clearmind Medicine Inc. | -3.94 Million USD | -4186.37% |
| Kronos Bio, Inc. | -36.05 Million USD | -368.73% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1896.11% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 11689.937% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -211.479% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1272.248% |
| ImmunityBio, Inc. | 618.22 Million USD | 127.336% |
| Korro Bio, Inc. | -132.94 Million USD | -27.119% |
| Kineta, Inc. | -4.54 Million USD | -3621.559% |
| BioVie Inc. | -17.73 Million USD | -853.038% |
| Codexis, Inc. | -43.27 Million USD | -290.553% |
| Celularity Inc. | 65.19 Million USD | 359.236% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -5232.786% |
| Celcuity Inc. | 6.78 Million USD | 2591.277% |
| Virax Biolabs Group Limited | -3.36 Million USD | -4922.253% |
| Cibus, Inc. | -8.07 Million USD | -1992.052% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -3896.122% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 3797.943% |
| IN8bio, Inc. | -16.38 Million USD | -931.155% |
| Kodiak Sciences Inc. | -103.87 Million USD | -62.692% |
| Annexon, Inc. | -193.75 Million USD | 12.779% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 469533.333% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -865.747% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -4710.589% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 116.03% |
| Eyenovia, Inc. | 1.25 Million USD | 13526.212% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 728.121% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5111.101% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -408.305% |
| Arcellx, Inc. | -296.95 Million USD | 43.091% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -766.38% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -187.042% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -715.342% |
| Moolec Science SA | 117.61 Thousand USD | 143784.533% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -340.105% |
| Geron Corporation | 14.76 Million USD | 1244.882% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -345.688% |
| Royalty Pharma plc | 5.65 Billion USD | 102.987% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -19.499% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -2317.882% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -3051.23% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -20.084% |
| Humacyte, Inc. | -22.48 Million USD | -651.561% |
| Structure Therapeutics Inc. | -124.33 Million USD | -35.915% |
| 89bio, Inc. | -289.05 Million USD | 41.535% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -569.503% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -9378.183% |
| Genelux Corporation | -6.89 Million USD | -2349.572% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -444.113% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 302.151% |
| Notable Labs, Ltd. | -9.77 Million USD | -1628.682% |
| Liquidia Corporation | -80.17 Million USD | -110.781% |
| Mustang Bio, Inc. | -3.73 Million USD | -4423.448% |
| Immunovant, Inc. | -635.22 Million USD | 73.396% |
| Quantum-Si incorporated | -118.55 Million USD | -42.544% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -862.173% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -3979.073% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 2205.344% |
| Acasti Pharma Inc. | -23 Million USD | -634.606% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -4918.845% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -940.016% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -22.692% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -5322.862% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -660.148% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -810.097% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 0.167% |
| PepGen Inc. | -60.67 Million USD | -178.55% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -635.533% |
| United Therapeutics Corporation | -507.7 Million USD | 66.713% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -783.593% |
| Solid Biosciences Inc. | -47.75 Million USD | -253.918% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -19503.08% |
| Immuneering Corporation | -54.94 Million USD | -207.585% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3920.375% |
| Silo Pharma, Inc. | -3.52 Million USD | -4695.154% |
| Belite Bio, Inc | -87.27 Million USD | -93.645% |
| XOMA Corporation | -29 Million USD | -482.745% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -139.043% |
| Bionomics Limited | 227 Million USD | 174.444% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -45.333% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -6571.773% |
| uniQure N.V. | -102.95 Million USD | -64.152% |
| Cassava Sciences, Inc. | -121.13 Million USD | -39.509% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3957.11% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 512.679% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1312.892% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -5361.703% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 159530.189% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5111.101% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1997.765% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -2178.803% |
| Altimmune, Inc. | -134.48 Million USD | -25.66% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 185.324% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -6571.773% |
| Compugen Ltd. | -12.9 Million USD | -1209.64% |
| Peak Bio, Inc. | 10.34 Million USD | 1734.366% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -59615.901% |
| Benitec Biopharma Inc. | -50.58 Million USD | -234.103% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -61.97% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 960.249% |
| Zura Bio Limited | -99.8 Million USD | -69.324% |
| PolyPid Ltd. | 6.17 Million USD | 2838.995% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 328.003% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 960.249% |
| Instil Bio, Inc. | 75.35 Million USD | 324.258% |
| argenx SE | -2.02 Billion USD | 91.67% |
| Immunome, Inc. | -97.02 Million USD | -74.171% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -651.26% |
| Verona Pharma plc | -220.44 Million USD | 23.338% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -135.557% |
| Shattuck Labs, Inc. | -121.42 Million USD | -39.178% |
| CervoMed Inc. | -7.79 Million USD | -2068.604% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 8.897% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -3764.532% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -28.28% |
| Moolec Science SA | 117.61 Thousand USD | 143784.533% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -7286.263% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1162.976% |
| AnaptysBio, Inc. | -18.15 Million USD | -831.056% |
| Design Therapeutics, Inc. | -18.15 Million USD | -831.107% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -140.116% |
| NeurAxis, Inc. | 145.7 Thousand USD | 116089.019% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1604.594% |
| Lumos Pharma, Inc. | -28.49 Million USD | -493.114% |
| Achilles Therapeutics plc | -126.92 Million USD | -33.147% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -135.557% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -25672.193% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -713.504% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 11689.937% |
| Nutriband Inc. | -251.65 Thousand USD | -67053.308% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1183.092% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -2171.452% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 149.676% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 812.012% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 62.233% |
| Palisade Bio, Inc. | -12.06 Million USD | -1300.945% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -20.444% |
| Beam Therapeutics Inc. | -262.72 Million USD | 35.675% |
| Neurogene Inc. | -131.95 Million USD | -28.071% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 874.642% |
| AEON Biopharma, Inc. | -4.88 Million USD | -3363.033% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 55.196% |
| Sesen Bio, Inc. | -112.55 Million USD | -50.148% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -69.233% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -7098.079% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -333.034% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -102.92% |
| Athira Pharma, Inc. | -88.99 Million USD | -89.885% |
| Vaccinex, Inc. | -1.28 Million USD | -13020.807% |
| HCW Biologics Inc. | 2.85 Million USD | 6015.827% |
| XOMA Corporation | -29 Million USD | -482.745% |
| Nektar Therapeutics | 210.24 Million USD | 180.382% |
| Arvinas, Inc. | -313.8 Million USD | 46.145% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 10513.275% |
| Merus N.V. | -192.88 Million USD | 12.385% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 381.73% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -2335.803% |
| Rezolute, Inc. | -68.16 Million USD | -147.911% |
| Clene Inc. | 3.34 Million USD | 5159.76% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1181.535% |
| BeyondSpring Inc. | -13.75 Million USD | -1128.615% |
| Synlogic, Inc. | -6.68 Million USD | -2427.988% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 15002.646% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1898.77% |
| Peak Bio, Inc. | 10.34 Million USD | 1734.366% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -105.042% |
| Krystal Biotech, Inc. | -350.23 Million USD | 51.748% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 236.15% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -5252.813% |
| MannKind Corporation | 143.89 Million USD | 217.441% |
| Ikena Oncology, Inc. | -109.15 Million USD | -54.821% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -2132.149% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -410.562% |
| Gossamer Bio, Inc. | 180.35 Million USD | 193.702% |
| CohBar, Inc. | -5.93 Million USD | -2749.497% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -468.092% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3801.183% |
| Legend Biotech Corporation | -949.39 Million USD | 82.2% |
| Mural Oncology plc | -255.84 Million USD | 33.945% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 624.588% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -3487.536% |
| Disc Medicine, Inc. | -358.28 Million USD | 52.831% |
| Champions Oncology, Inc. | 4.81 Million USD | 3611.97% |
| REGENXBIO Inc. | 54.76 Million USD | 408.567% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -62745.519% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -11.9% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1775.232% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -109.457% |
| Vaxart, Inc. | -8.24 Million USD | -1950.673% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -236.78% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -32.894% |
| Cellectis S.A. | -43.85 Million USD | -285.352% |
| Longeveron Inc. | -2.9 Million USD | -5711.417% |
| Repare Therapeutics Inc. | -107.85 Million USD | -56.684% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 117.451% |
| Inozyme Pharma, Inc. | 12 Million USD | 1507.831% |
| Revolution Medicines, Inc. | -608.2 Million USD | 72.214% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -13639.512% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 36.256% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -12.61% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -980.054% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -22737.297% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.233% |
| Denali Therapeutics Inc. | -74.86 Million USD | -125.734% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1309.275% |
| Veru Inc. | 4.77 Million USD | 3635.504% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1402.721% |
| Cingulate Inc. | 3.08 Million USD | 5582.108% |
| Passage Bio, Inc. | 4.58 Million USD | 3785.845% |
| Context Therapeutics Inc. | -14.44 Million USD | -1069.536% |
| Exicure, Inc. | 5.84 Million USD | 2989.314% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 26.643% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -327.081% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1177.025% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -187.306% |
| Nuvalent, Inc. | -335.38 Million USD | 49.612% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 9844.105% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -126.895% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1800.967% |
| OmniAb, Inc. | 9.2 Million USD | 1936.314% |
| Anew Medical, Inc. | 1.43 Million USD | 11897.566% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1131.611% |
| Lipocine Inc. | -4.75 Million USD | -3454.374% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -53.873% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1209.553% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -233.595% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 778.917% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -2414.447% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -156.727% |
| Ocugen, Inc. | -32.52 Million USD | -419.652% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -97.483% |
| Q32 Bio Inc. | -37.94 Million USD | -345.336% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -26810.191% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1149.139% |
| Equillium, Inc. | -22.39 Million USD | -654.716% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -560.967% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -417.967% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -68066.912% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 226.077% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 5384.428% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 51553.99% |
| Dominari Holdings Inc. | 195 Thousand USD | 86764.615% |
| Edesa Biotech, Inc. | -5.26 Million USD | -3108.637% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1795.211% |
| Bio-Techne Corporation | 267.74 Million USD | 163.118% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -942.606% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -43.103% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1911.139% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1235.831% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 31.056% |
| Nkarta, Inc. | 57.29 Million USD | 394.937% |
| BioCardia, Inc. | 212 Thousand USD | 79815.094% |
| Iterum Therapeutics plc | 13.43 Million USD | 1357.598% |